ondansetron
Generic: ondansetron
Labeler: ipca laboratories limitedDrug Facts
Product Profile
Brand Name
ondansetron
Generic Name
ondansetron
Labeler
ipca laboratories limited
Dosage Form
TABLET, ORALLY DISINTEGRATING
Routes
Active Ingredients
ondansetron 4 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
83980-012
Product ID
83980-012_3582cf26-d9a0-4b93-93a1-d1824e55fc19
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209389
Listing Expiration
2026-12-31
Marketing Start
2025-06-19
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
83980012
Hyphenated Format
83980-012
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ondansetron (source: ndc)
Generic Name
ondansetron (source: ndc)
Application Number
ANDA209389 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 4 mg/1
Packaging
- 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-01)
- 1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-10)
- 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-13)
- 3 BLISTER PACK in 1 CARTON (83980-012-83) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Packages (4)
83980-012-01
100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-01)
83980-012-10
1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-10)
83980-012-13
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-13)
83980-012-83
3 BLISTER PACK in 1 CARTON (83980-012-83) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3582cf26-d9a0-4b93-93a1-d1824e55fc19", "openfda": {"nui": ["N0000175817", "N0000175818"], "upc": ["0383980012134", "0383980013131"], "unii": ["4AF302ESOS"], "rxcui": ["104894", "312087"], "spl_set_id": ["8e24f935-87fe-4b6a-b265-60b1039f38d5"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Ipca Laboratories Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-01)", "package_ndc": "83980-012-01", "marketing_start_date": "20250619"}, {"sample": false, "description": "1000 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-10)", "package_ndc": "83980-012-10", "marketing_start_date": "20250619"}, {"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (83980-012-13)", "package_ndc": "83980-012-13", "marketing_start_date": "20250619"}, {"sample": false, "description": "3 BLISTER PACK in 1 CARTON (83980-012-83) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK", "package_ndc": "83980-012-83", "marketing_start_date": "20250619"}], "brand_name": "Ondansetron", "product_id": "83980-012_3582cf26-d9a0-4b93-93a1-d1824e55fc19", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "83980-012", "generic_name": "Ondansetron", "labeler_name": "Ipca Laboratories Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "4 mg/1"}], "application_number": "ANDA209389", "marketing_category": "ANDA", "marketing_start_date": "20250619", "listing_expiration_date": "20261231"}